MAIA Biotechnology, Inc. Share Price

MAIA Biotechnology, Inc. Share Price

AMEX: MAIA | Micro Cap
$1.13
-$0.06 (-5.04%) Last updated on 30 Oct, 2026 | 21:47 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MAIA Biotechnology, Inc. Stock Performance

Open
$1.13
Prev. Close
$1.19
Circuit Range
N/A
Day Range
$1.13 - $1.13
Year Range
$0.88 - $3.14
Volume
526
Average Traded
$1.13

MAIA Biotechnology, Inc. Share Price Today

As of 30 October 2026, MAIA Biotechnology, Inc.'s share price is $1.13. The stock opened at $1.13, compared to its previous close of $1.19. During today's trading session, MAIA Biotechnology, Inc.'s share price traded between $1.13 and $1.13, with an average price of $1.13. Over the past 52 weeks, the stock has recorded a high of $3.14 and a low of $0.88. In terms of performance, MAIA Biotechnology, Inc.'s share price has declined by 15.36% over the last six months and is down 8.13% on a year-on-year basis.

MAIA Biotechnology, Inc. Share Price Chart

Line chart of the MAIA Biotechnology, Inc. price trend over the selected period. The price fell overall, ranging from 1.13 to 1.17, ending at 1.13.
$1.13$1.13
L
Show Current Price
H

MAIA Biotechnology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$36.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.43
Revenue (TTM)
$0.00
Return On Equity (TTM)
-129.84%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
10.79%

MAIA Biotechnology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.90-$3.63-$6.37-$7.94
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A59.21%-75.48%-24.65%

MAIA Biotechnology, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$16.22-$19.77-$23.25-$22.40
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21.89%-17.60%3.66%

About MAIA Biotechnology, Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

MAIA Biotechnology, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.18
$1.13
-4.24%
Sep 2026
$1.30
$1.18
-15.71%
Aug 2026
$1.24
$1.40
+10.24%
Jul 2026
$1.43
$1.27
-10.56%
Jun 2026
$1.36
$1.42
+2.53%
May 2026
$1.33
$1.39
+3.75%
Apr 2026
$1.40
$1.33
-3.96%
Mar 2026
$2.18
$1.39
-37.67%
Feb 2026
$2.35
$2.23
-5.51%
Jan 2026
$1.59
$2.36
+56.29%
Dec 2025
$1.33
$1.51
+31.30%
Nov 2025
$1.23
$1.15
-6.50%

MAIA Share Price FAQs